Royal Bank Of Canada Acrivon Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $579 Billion
- Q3 2025
A detailed history of Royal Bank Of Canada transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 948 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
948
Previous 31
2958.06%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ACRV
# of Institutions
47Shares Held
18.2MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.54MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY767KShares$00.0% of portfolio